弗拉芒地区纤维肌痛女性的性欲、抑郁症状与药物使用情况
Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders.
作者信息
Van Overmeire Roel, Vesentini Lara, Vanclooster Stephanie, Muysewinkel Emilie, Bilsen Johan
机构信息
Mental Health and Wellbeing Research Group, Department of Public Health, Vrije Universiteit Brussel, Ixelles, Belgium.
Mental Health and Wellbeing Research Group, Department of Public Health, Vrije Universiteit Brussel, Ixelles, Belgium.
出版信息
Sex Med. 2022 Feb;10(1):100457. doi: 10.1016/j.esxm.2021.100457. Epub 2021 Nov 25.
BACKGROUND
Fibromyalgia (FM) is associated with sexual dysfunction, though much less is known about the sexual desire, and especially dyadic and solitary sexual desire, among women with fibromyalgia.
AIM
To investigate on the one hand the global sexual desire, the dyadic sexual and solitary sexual desire, and on the other hand the association with depressive symptoms, fibromyalgia symptoms and medication use among women with fibromyalgia in Flanders, Belgium.
METHODS
An online survey was spread through the Flemish league for Fibromyalgia Patients to be completed by women with fibromyalgia. The sexual desire inventory-2 (SDI-2) was used to measure sexual desire (global, dyadic, solitary), the VASFIQ for fibromyalgia symptoms, and the PHQ-2 for depressive symptoms, while also including questions on demographic factors (time since FM, age) and medication usage (antidepressants, pain medication, sleeping medication).
MAIN OUTCOME MEASURE
Global sexual desire, dyadic sexual desire and solitary sexual desire were studied in relation to depressive symptoms, medication use and fibromyalgia symptoms.
RESULTS
One hundred and three women with FM answered the survey. Depressive symptoms were significantly associated with a lower global, dyadic and solitary sexual desire, as was the use of antidepressant medication. The association between solitary sexual desire and depressive symptoms disappeared when controlled for antidepressant medication. Age, fibromyalgia symptoms nor time since diagnosis were significantly associated with any form of sexual desire.
CONCLUSION
Depressive symptoms and antidepressant medication, and not fibromyalgia symptoms, were associated with decreased sexual desire of women with FM. As antidepressant medication and depressive symptoms are associated with a decreased sexual desire, more attention should be paid towards the mental health issues associated with fibromyalgia, as well as the prescription of antidepressant medication. This study is the first to investigate sexual desire among women with fibromyalgia in Flanders, and one of the few internationally to have done so. It is limited by its cross-sectional design, and for not providing information on men with FM. Van Overmeire R, Vesentini L, Vanclooster S, et al. Sexual Desire, Depressive Symptoms and Medication Use Among Women With Fibromyalgia in Flanders. Sex Med 2022;10:100457.
背景
纤维肌痛（FM）与性功能障碍有关，不过对于纤维肌痛女性的性欲，尤其是双方性欲和个体性欲，人们了解得还很少。
目的
一方面调查纤维肌痛女性的总体性欲、双方性欲和个体性欲，另一方面调查其与抑郁症状、纤维肌痛症状及药物使用之间的关联，研究对象为比利时弗拉芒地区的纤维肌痛女性。
方法
通过弗拉芒纤维肌痛患者联盟开展一项在线调查，由纤维肌痛女性完成。使用性欲量表-2（SDI-2）来测量性欲（总体、双方、个体），用视觉模拟评分法评估纤维肌痛症状，用患者健康问卷-2评估抑郁症状，同时还包括关于人口统计学因素（纤维肌痛患病时长、年龄）和药物使用情况（抗抑郁药、止痛药、安眠药）的问题。
主要观察指标
研究总体性欲、双方性欲和个体性欲与抑郁症状、药物使用及纤维肌痛症状之间有何关系。
结果
103名纤维肌痛女性回答了该调查。抑郁症状与较低的总体、双方和个体性欲显著相关，使用抗抑郁药物也有同样情况。在控制了抗抑郁药物因素后，个体性欲与抑郁症状之间的关联消失。年龄、纤维肌痛症状以及确诊后的时长与任何形式的性欲均无显著关联。
结论
与纤维肌痛女性性欲降低有关的是抑郁症状和抗抑郁药物，而非纤维肌痛症状本身。由于抗抑郁药物和抑郁症状与性欲降低有关，所以应更加关注与纤维肌痛相关的心理健康问题以及抗抑郁药物的处方。本研究是首次对弗拉芒地区纤维肌痛女性的性欲进行调查，也是国际上为数不多的此类研究之一。其局限性在于采用横断面设计，且未提供纤维肌痛男性的相关信息。范·奥弗迈尔R、韦森蒂尼L、万克洛斯特S等。弗拉芒地区纤维肌痛女性的性欲、抑郁症状及药物使用情况。《性医学》2022；10：100457 。
Zotero 插件